Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants

This cohort study evaluates the cancer spectrum and risks in children and adults with germline PTEN variants.

[1]  Ayman Al Baz,et al.  Genomic architecture of autism from comprehensive whole-genome sequence annotation , 2022, Cell.

[2]  J. Schuurs-Hoeijmakers,et al.  Cancer risks by sex and variant type in PTEN Hamartoma Tumor Syndrome. , 2022, Journal of the National Cancer Institute.

[3]  B. Karlan,et al.  Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  A. Jemal,et al.  Cancer statistics for adolescents and young adults, 2020 , 2020, CA: a cancer journal for clinicians.

[5]  F. Cheng,et al.  Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors , 2020, Nature Communications.

[6]  C. Eng,et al.  Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations , 2020, JAMA network open.

[7]  Matthew W. Mosconi,et al.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism , 2019, Cell.

[8]  C. Eng,et al.  The Clinical Spectrum of PTEN Mutations. , 2020, Annual review of medicine.

[9]  B. Eickholt,et al.  PTEN in Autism and Neurodevelopmental Disorders. , 2019, Cold Spring Harbor perspectives in medicine.

[10]  Robert Huether,et al.  Gene‐specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel , 2018, Human mutation.

[11]  C. Eng,et al.  65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine. , 2018, Endocrine-related cancer.

[12]  J. Barnholtz-Sloan,et al.  Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Møller,et al.  Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome , 2014, Familial Cancer.

[14]  V. Brouste,et al.  High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome , 2013, Journal of Medical Genetics.

[15]  P. Pandolfi,et al.  The functions and regulation of the PTEN tumour suppressor , 2012, Nature Reviews Molecular Cell Biology.

[16]  C. Eng,et al.  Lifetime Cancer Risks in Individuals with Germline PTEN Mutations , 2012, Clinical Cancer Research.

[17]  Charis Eng,et al.  A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. , 2011, American journal of human genetics.

[18]  C Eng,et al.  Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations , 2005, Journal of Medical Genetics.

[19]  C. Eng.  Will the real Cowden syndrome please stand up: revised diagnostic criteria , 2000, Journal of medical genetics.

[20]  F. Arwert,et al.  The Cowden syndrome: a clinical and genetic study in 21 patients , 1986, Clinical genetics.

[21]  M. Wolf,et al.  Gowden's disease. A cutaneous marker of breast cancer , 1978 .